Literature DB >> 24577612

Differential expression of two-component systems, pmrAB and phoPQ, with different growth phases of Klebsiella pneumoniae in the presence or absence of colistin.

So Yeon Kim1, Hyeon Jin Choi, Kwan Soo Ko.   

Abstract

We explored whether expression of pmrAB, pmrD, and phoPQ is dependent on growth phase with or without colistin exposure in colistin-resistant Klebsiella pneumoniae strains. In four colistin-resistant K. pneumoniae strains, the expression of pmrAB, pmrD, and phoPQ was evaluated at mid-log, late-log, and stationary phases in the absence or presence of colistin, by qRT-PCR. The expression pattern in the presence of colistin was different from that in the absence of colistin: overall, pmrAB, pmrD, and phoPQ expressed the highest at the stationary phase in the absence of colistin, but the expression of pmrD and phoPQ decreased with the growth in the presence of colistin. Exposure to colistin might change the expression patterns of two-component regulatory systems in colistin-resistant K. pneumoniae strains.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577612     DOI: 10.1007/s00284-014-0549-0

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  14 in total

1.  Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii.

Authors:  Young Kyoung Park; Ji Young Choi; Dongwoo Shin; Kwan Soo Ko
Journal:  Int J Antimicrob Agents       Date:  2011-04-14       Impact factor: 5.283

Review 2.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

3.  Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy.

Authors:  Rachel L Soon; Roger L Nation; Marina Harper; Ben Adler; John D Boyce; Chun-Hong Tan; Jian Li; Ian Larson
Journal:  Int J Antimicrob Agents       Date:  2011-09-16       Impact factor: 5.283

4.  Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.

Authors:  Dror Marchaim; Teena Chopra; Jason M Pogue; Federico Perez; Andrea M Hujer; Susan Rudin; Andrea Endimiani; Shiri Navon-Venezia; Jatinder Hothi; Jessica Slim; Christopher Blunden; Maryann Shango; Paul R Lephart; Hossein Salimnia; Deborah Reid; Judy Moshos; Wasif Hafeez; Suchitha Bheemreddy; Ting-Yi Chen; Sorabh Dhar; Robert A Bonomo; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 5.  Resistance to polymyxins: Mechanisms, frequency and treatment options.

Authors:  Matthew E Falagas; Petros I Rafailidis; Dimitrios K Matthaiou
Journal:  Drug Resist Updat       Date:  2010-06-17       Impact factor: 18.500

6.  Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.

Authors:  Rachel L Soon; Roger L Nation; Stewart Cockram; Jennifer H Moffatt; Marina Harper; Ben Adler; John D Boyce; Ian Larson; Jian Li
Journal:  J Antimicrob Chemother       Date:  2010-11-16       Impact factor: 5.790

7.  Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster.

Authors:  Anastasia Antoniadou; Flora Kontopidou; Garifalia Poulakou; Evangelos Koratzanis; Irene Galani; Evangelos Papadomichelakis; Petros Kopterides; Maria Souli; Apostolos Armaganidis; Helen Giamarellou
Journal:  J Antimicrob Chemother       Date:  2007-02-16       Impact factor: 5.790

8.  Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43.

Authors:  Hsin-Yao Cheng; Yi-Fong Chen; Hwei-Ling Peng
Journal:  J Biomed Sci       Date:  2010-07-24       Impact factor: 8.410

9.  Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.

Authors:  Ji-Yoeun Suh; Jun Seong Son; Doo Ryeon Chung; Kyong Ran Peck; Kwan Soo Ko; Jae-Hoon Song
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

10.  Differential Role of Two-Component Regulatory Systems (phoPQ and pmrAB) in Polymyxin B Susceptibility of Pseudomonas aeruginosa.

Authors:  Daniel Owusu-Anim; Dong H Kwon
Journal:  Adv Microbiol       Date:  2012-03-01
View more
  11 in total

1.  Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.

Authors:  Matthew E Wand; Lucy J Bock; Laura C Bonney; J Mark Sutton
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

2.  Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance.

Authors:  Meredith S Wright; Yo Suzuki; Marcus B Jones; Steven H Marshall; Susan D Rudin; David van Duin; Keith Kaye; Michael R Jacobs; Robert A Bonomo; Mark D Adams
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Colistin.

Authors:  Nicolas Grégoire; Vincent Aranzana-Climent; Sophie Magréault; Sandrine Marchand; William Couet
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

Review 4.  Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.

Authors:  Yan Zhu; Irene Galani; Ilias Karaiskos; Jing Lu; Su Mon Aye; Jiayuan Huang; Heidi H Yu; Tony Velkov; Helen Giamarellou; Jian Li
Journal:  J Infect       Date:  2019-07-30       Impact factor: 6.072

6.  Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains.

Authors:  Myung-Jin Choi; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

Review 7.  Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria.

Authors:  Abiola O Olaitan; Serge Morand; Jean-Marc Rolain
Journal:  Front Microbiol       Date:  2014-11-26       Impact factor: 5.640

8.  Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus.

Authors:  Jinxin Zhao; Soon-Ee Cheah; Kade D Roberts; Roger L Nation; Philip E Thompson; Tony Velkov; Zongjun Du; Matthew D Johnson; Jian Li
Journal:  mSphere       Date:  2016-07-27       Impact factor: 4.389

9.  Colistin Heteroresistance in Klebsiella Pneumoniae Isolates and Diverse Mutations of PmrAB and PhoPQ in Resistant Subpopulations.

Authors:  Hae Suk Cheong; So Yeon Kim; Yu Mi Wi; Kyong Ran Peck; Kwan Soo Ko
Journal:  J Clin Med       Date:  2019-09-11       Impact factor: 4.241

10.  Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Yuan Tian; QiaoYu Zhang; LiRong Wen; JianSen Chen
Journal:  Microbiol Spectr       Date:  2021-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.